Garrabou J, Gmez-Gras D, Medrano A, Cerrano C, Ponti M, Schlegel R, Bensoussan N, Turicchia E, Vasilis Gerovasileiou MS, Teixido N, Mirasole A, Tamburello L, Cebrian E, Rilov G, Ledoux JB, Souissi JB, Khamassi F, Ghanem R, Benabdi M, Grimes S, Ocaa O, Bazairi H, Hereu B, Linares C, Kersting DK, la Rovira G, Ortega J, Casals D, Pags-Escol M, Margarit N, Capdevila P, Verdura J, Ramos A, Izquierdo A, Barbera C, Rubio-Portillo E, Anton I, Lpez-Sendino P, Daz D, Vzquez-Luis M, Duarte C, Marb N, Aspillaga E, Espinosa F, Grech D, Guala I, Azzurro E, Farina S, Gambi MC, Chimienti G, Montefalcone M, Azzola A, Mantas TP, Fraschetti S, Ceccherelli G, Kipson S, Bakran-Petricioli T, Petricioli D, Jimenez C, Katsanevakis S, Kizilkaya IT, Kizilkaya Z, Sartoretto S, Elodie R, Ruitton S, Comeau S, Gattuso JP, Harmelin JG (2022) Marine heatwaves drive recurrent mass mortalities in the Mediterranean Sea

We encourage you to Explore High-Purity Research Peptides to see the difference that quality makes across a wide spectrum of compounds
The dual-receptor action offers enhanced benefits for blood sugar control and weight management, suppressing appetite and slowing digestion
The active ingredient in the incretin mimetic is dulaglutide, which shares 90% of the amino acid sequence with naturally occurring GLP-1
Apr 2015;23(4):879-85